Streetbeat News

Stock Prices

EIGR

Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) announced a 1-for-30 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement. The split will be effective on January 5, 2024, with post-split trading starting on January 8, 2024. The split was approved by stockholders and the Board on December 28, 2023, and will reduce outstanding shares from 44.4 million to approximately 1.5 million. Adjustments will be made to outstanding equity awards and the number of shares issuable under equity incentive plans.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:32 pm

INAB

IN8bio, Inc. (NASDAQ:INAB) reported positive clinical data for its gamma-delta T cell therapies, particularly INB-100, which showed durable complete remissions in leukemia patients. The company also presented promising data for INB-200 and INB-400 in treating glioblastoma multiforme (GBM). A private placement raised initial gross proceeds of $14.4 million, extending the cash runway into 2025, with the potential for additional capital. Dr. Corinne Epperly was appointed to the Board of Directors. IN8bio outlined its 2024 pipeline goals, including further trials for INB-100, INB-200, INB-300, and INB-400.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:31 pm

AAGR

African Agriculture Holdings Inc (NASDAQ:AAGR) has entered into a multi-year supply agreement with South Korea's Dr. Kahn to supply alfalfa. The deal involves the production from 700 hectares and is expected to contribute to African Agriculture's revenue in 2024 and 2025. The agreement is seen as a validation of African Agriculture's growth strategy and its role in global food security. AAGR's stock traded 5.98% lower at $1.10 in premarket trading.

Portfolio Pulse from Anusuya Lahiri

January 04, 2024 | 1:30 pm

AEE

B of A Securities analyst Julien Dumoulin-Smith downgraded Ameren (NYSE:AEE) from Buy to Neutral and set a price target of $77.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:24 pm

CXM

Sprinklr has appointed Trac Pham as interim COO and authorized a $100M stock buyback program. The company reaffirms its Q4 and FY24 financial guidance. Pham, former CFO of Synopsys and current Sprinklr board member, will focus on improving the go-to-market strategy while assisting in the search for a permanent President and COO. The buyback reflects Sprinklr's strong balance sheet and cash flow, aiming to enhance stockholder value. The repurchase plan will be conducted under SEC rules and is expected to be completed within 2024.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:22 pm

BBWI

Barclays analyst Adrienne Yih has downgraded Bath & Body Works (NYSE:BBWI) from Overweight to Equal-Weight while increasing the price target from $37 to $45.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:22 pm

FDMT

4D Molecular Therapeutics (4DMT) reported clinical pipeline progress, upcoming milestones, and organizational updates. The company remains well-capitalized with $300M in estimated cash, sufficient to fund operations into H1 2026. Key clinical advancements include progress in wet AMD, DME, and CF programs, with Phase 2 trial data for 4D-150 in wet AMD and DME expected in 2024. The company also announced a partnership with Arbor Biotechnologies for CNS diseases and appointed Noriyuki Kasahara as Chief Scientific Officer. Upcoming milestones include data presentations, trial updates, and IND filings across its ophthalmology, pulmonology, cardiology, and rare inherited retinal disorders portfolios.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:20 pm

STZ

Constellation Brands, Inc. (STZ) is set to release its Q3 earnings report on Jan. 5, 2024, with expected earnings of $3.00 per share on revenue of $2.55 billion. JPMorgan analyst Andrea Teixeira maintains an Overweight rating on STZ but lowered the price target from $309 to $301. The article also discusses how to earn monthly income from STZ's dividends, which currently yield 1.47%, and provides examples of the number of shares needed to achieve certain income goals. STZ shares fell 1% to close at $241.42 on Wednesday.

Portfolio Pulse from Avi Kapoor

January 04, 2024 | 1:20 pm

NKLA

Nikola Corporation reported the production of 42 Class 8 hydrogen fuel cell vehicles and the wholesale of 35 of these vehicles to customers in the US and Canada for the year 2023.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:19 pm

DSS

DSS, a leader in anti-counterfeit, authentication, and diversion protection technologies, announced that its Co. Chairman has purchased 672,173 shares of the company's stock. This move could signal confidence in the company's future prospects and may influence the stock's performance in the short term.

Portfolio Pulse from Benzinga Newsdesk

January 04, 2024 | 1:17 pm